"Labetalol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
| Descriptor ID |
D007741
|
| MeSH Number(s) |
D02.033.100.291.460 D02.065.793.324 D02.092.063.291.460
|
| Concept/Terms |
Dilevalol- Dilevalol
- Labetalol, (R,R)-Isomer
- R,R-Labetalol
- R,R Labetalol
|
Below are MeSH descriptors whose meaning is more general than "Labetalol".
Below are MeSH descriptors whose meaning is more specific than "Labetalol".
This graph shows the total number of publications written about "Labetalol" by people in this website by year, and whether "Labetalol" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 0 | 1 | 1 |
| 2018 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Labetalol" by people in Profiles.
-
Without Warning: Scleroderma Renal Crisis. Am J Med. 2019 02; 132(2):175-178.
-
Autonomic dysreflexia manifested by severe hypertension. Med Sci Monit. 2004 Dec; 10(12):CS77-9.
-
Effects of dilevalol, metoprolol and atenolol on left ventricular mass and function in nonelderly and elderly hypertensive patients. Am J Cardiol. 1989 Jun 05; 63(19):69I-74I.